What is Cogent Biosciences, Inc.'s stock issuance proceeds?

Cogent Biosciences, Inc. (COGT) reported stock issuance proceeds of $5.76M in Q1 2026.

How has Cogent Biosciences, Inc.'s stock issuance proceeds changed year-over-year?

Cogent Biosciences, Inc.'s stock issuance proceeds increased by 4132.4% year-over-year, from $136K to $5.76M.

What does stock issuance proceeds mean?

Cash received from issuing common stock — IPOs, secondary offerings, DRIP, employee stock purchase plans, and option exercises.

Cogent Biosciences, Inc. COGT Stock Issuance Proceeds

Stock Issuance Proceeds at other companies

IncyteINCY

$97.93M+2,923%

Tango TherapeuticsTNGX

$17.61M+880,150%

CG OncologyCGON

$391.55M+57,312%

Scholar RockSRRK

$98M+1,852%

CRISPR TherapeuticsCRSP

-$722K-108%

ExelixisEXEL

$7.47M-35.7%

Other financials

Income statement

See full

Operating income-$103.6M-38.3%

Net income-$97.4M-35.2%

EPS (diluted)-$0.53-1.9%

Balance sheet

See full

Cash & equivalents$241.2M+91.4%

Total debt$15.5M-9.4%

Total equity$607.7M+177%

Total assets$903.0M+218%

Cash flow

See full

Operating cash flow-$86.9M-30.6%

CapEx$449.0K-17.9%

Free cash flow-$87.3M-30.2%

Valuation

See full

Market cap$5.9B+816%

Enterprise value$5.68B+951%

P/S749.8×—

Profitability

See full

Operating margin-1,044.3%—

Net margin-950.4%—

FCF margin-184.7%—

Returns & leverage

See full

Return on equity-85.7%+1.7pp

Debt / equity0×-0.1×

Current ratio15.1×+10.0×

Where this comes from

Reported directly by Cogent Biosciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromStockOptionsExercised.

The official record: Cogent Biosciences, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Cogent Biosciences, Inc.'s stock issuance proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Cogent Biosciences, Inc.'s stock issuance proceeds?: Cogent Biosciences, Inc. (COGT) reported stock issuance proceeds of $5.76M in Q1 2026.
How has Cogent Biosciences, Inc.'s stock issuance proceeds changed year-over-year?: Cogent Biosciences, Inc.'s stock issuance proceeds increased by 4132.4% year-over-year, from $136K to $5.76M.
What does stock issuance proceeds mean?: Cash received from issuing common stock — IPOs, secondary offerings, DRIP, employee stock purchase plans, and option exercises.